Asst. Prof. Dr. Md. Mukitul Huda

Asst. Prof. Dr. Md. Mukitul Huda – Top Oncologist & Cancer Specialist, Khulna

Asst. Prof. Dr. Md. Mukitul Huda is an Assistant Professor and the Head of the Department of Radiotherapy at Khulna Medical College & Hospital, Khulna, with over 28 years of distinguished clinical, academic, and systemic oncology experience. As an eminent Oncologist and Cancer Specialist, he provides expert care for severe and complex hematological and solid malignancies, including acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, Hodgkin lymphoma, and diffuse large B-cell lymphoma. Patients seeking expert oncological evaluation receive evidence-based treatments tailored to halt disease progression, manage acute cancer-related crises, and achieve long-term remission. His medical practice combines high-precision cancer diagnostics with individualized, systemic patient care plans.

Professional Biography

Asst. Prof. Dr. Md. Mukitul Huda completed his MBBS degree, establishing a comprehensive clinical foundation in general medical sciences. Demonstrating a profound commitment to cancer care, he earned his Master of Philosophy (M.Phil) in Oncology, followed by the highly rigorous Fellowship of the College of Physicians and Surgeons (FCPS) in Radiotherapy. This exceptional dual qualification equips him with the advanced medical expertise required to manage highly complex malignancies using both systemic medical oncology (chemotherapy/targeted therapy) and precision radiation oncology. Finding the best Oncologist in Khulna leads patients to rely on his nearly three decades of academic leadership and specialized clinical expertise as the Head of the Department across premier government medical institutions.

His primary clinical focus includes intensive induction chemotherapy for acute myeloid leukemia, targeted immunotherapy and radiation protocols for lymphomas (Hodgkin and DLBCL), specialized bone marrow suppression management for multiple myeloma, and comprehensive radiation treatment planning for solid tumors. His diagnostic framework incorporates advanced bone marrow biopsy interpretation, PET-CT scan analysis, immunohistochemistry profiling, and comprehensive oncological risk stratification to formulate effective, long-term cancer survival strategies.

At-a-Glance Profile Card

Qualifications & Education

• MBBS – Bachelor of Medicine and Bachelor of Surgery

• M.Phil (Oncology) – Master of Philosophy in Oncology

• FCPS (Radiotherapy) – Fellow of the College of Physicians and Surgeons in Radiotherapy

Designation & Workplace

• Designation: Assistant Professor & Head Of Department (Radiotherapy)

• Workplace: Department of Radiotherapy, Khulna Medical College & Hospital, Khulna

Diseases Treated

• Acute myeloid leukemia (AML) requires intensive induction chemotherapy and bone marrow monitoring.

• Chronic lymphocytic leukemia (CLL) demands targeted biological therapies and vigilant monitoring.

• Multiple myeloma requires targeted proteasome inhibitors and bone lesion radiation therapy.

• Hodgkin lymphoma needs specialized combination chemotherapy and involved-field radiation.

• Diffuse large B-cell lymphoma (DLBCL) demands aggressive R-CHOP chemotherapy regimens.

• Breast cancer requires post-operative radiation and systemic hormonal/chemotherapy.

• Lung cancer demands concurrent chemoradiation or targeted biological agents.

• Colorectal cancer requires neoadjuvant or adjuvant chemotherapy and radiotherapy.

• Head and neck cancers demand highly precise intensity-modulated radiation therapy (IMRT).

• Prostate cancer requires hormonal ablation and localized prostate radiation therapy.

• Cervical cancer demands external beam radiation combined with brachytherapy.

• Brain tumors (Glioblastoma) require specialized cranial radiation and oral chemotherapy.

• Gastric (Stomach) cancer needs systemic oncological evaluation and chemotherapy.

• Soft tissue sarcomas require aggressive surgical margins and post-operative radiation.

• Ovarian cancer demands systemic platinum-based chemotherapy.

Clinical Specialties & Treatment Areas

• Hematological Malignancies (Blood Cancers): Precision management for aggressive cancers of the blood, bone marrow, and lymph nodes (Leukemia, Lymphoma, Myeloma) using systemic therapies.

• Radiation Oncology: Expert, precise delivery of high-energy radiation to shrink solid tumors (like breast, lung, and head/neck cancers) while preserving surrounding healthy tissue.

• Medical Oncology & Systemic Care: Comprehensive management of chemotherapy, immunotherapy, and targeted biological agents, leveraging 28 years of clinical experience to manage severe side effects.

Advanced Procedure Breakdown

Bone Marrow Aspiration and Biopsy

A critical diagnostic procedure for blood cancers like leukemia and multiple myeloma. Under local anesthesia, a special needle is inserted into the hip bone to extract liquid bone marrow and a small core of bone. Analyzing these samples under a microscope allows the oncologist to determine the exact type, genetic mutations, and extent of the blood cancer.

Advanced Radiation Treatment Planning

As an FCPS in Radiotherapy, Dr. Huda plans and oversees complex radiation therapies (such as 3D-CRT or IMRT). Using specialized CT scans, he maps the exact three-dimensional shape of a tumor. The radiation beams are then meticulously programmed to hit the tumor from multiple angles with millimeter precision, maximizing cancer cell death while sparing vital healthy organs nearby.

Systemic Chemotherapy & Targeted Therapy Protocols

The administration of powerful anti-cancer drugs intravenously. Dr. Huda designs specific multi-drug regimens (like R-CHOP for lymphomas) based on the tumor's pathology and the patient's genetic markers. He closely monitors patients for bone marrow suppression, organ toxicity, and infections, adjusting doses to ensure safety without compromising the cure rate.

Condition-Specific Deep Dives

Acute Myeloid Leukemia (AML)

A rapidly progressing, aggressive cancer of the blood and bone marrow. The marrow produces abnormal, immature white blood cells (myeloblasts) that crowd out healthy red cells, white cells, and platelets. Patients present with severe fatigue, easy bruising, bleeding gums, and life-threatening infections. Immediate, intensive "induction" chemotherapy in an isolated setting is required to force the disease into remission.

Multiple Myeloma

A cancer of plasma cells (a type of white blood cell) in the bone marrow. These cancerous cells produce abnormal proteins that can severely damage the kidneys and cause painful, destructive holes (lytic lesions) in the bones, particularly the spine and ribs. Treatment involves targeted therapies, immune modulators, and sometimes localized radiation to alleviate severe bone pain and prevent fractures.

Diffuse Large B-Cell Lymphoma (DLBCL)

The most common type of non-Hodgkin lymphoma. It is a fast-growing, aggressive cancer that starts in the lymphocytes (B-cells) and typically presents as rapidly enlarging, painless lymph nodes in the neck, armpits, or groin. Despite its aggressive nature, it is highly responsive to initial treatment, with a significant percentage of patients achieving complete cures using standard chemo-immunotherapy (R-CHOP).

The Doctor’s Clinical Approach

Asst. Prof. Dr. Md. Mukitul Huda utilizes nearly three decades of profound clinical wisdom to approach highly complex, life-threatening malignancies. His philosophy emphasizes an exhaustive, multidisciplinary approach to cancer staging, prioritizing rapid, aggressive interventions for fast-growing hematological cancers, and providing compassionate, empathetic counseling to guide patients and their families through the harrowing journey of cancer treatment.

Specialized Risk Factors

Emergency Callout: Immediate emergency medical evaluation is required if a chemotherapy patient develops a fever over 100.4°F (38°C) with chills (Febrile Neutropenia - a life-threatening lack of immune cells), experiences sudden, severe back pain with weakness or numbness in the legs (Spinal Cord Compression from a tumor), or develops sudden swelling of the face, neck, and arms with breathlessness (Superior Vena Cava Syndrome).

Certifications & Professional Memberships

• Member, Bangladesh Medical and Dental Council (BMDC)

• Fellow, Bangladesh College of Physicians and Surgeons (FCPS)

• Member, Bangladesh Society of Radiation Oncologists (BSRO)

Patient Visit Preparation Checklist

• Bring all prior biopsy reports, histopathology slides (blocks), PET-CT scans, MRI, and recent comprehensive blood tests (CBC, Renal, Liver function).

• Maintain a complete list of current prescription medications and any previous chemotherapy discharge summaries.

• Keep a detailed symptom diary noting severe fatigue, unexplained weight loss, night sweats, or new bone pain.

• Ensure a family member accompanies the patient to take detailed notes, as oncology consultations involve complex treatment protocols, scheduling, and side-effect management strategies.

Last Modified: October 27, 2026